BSE · ANL
Accretion Nutraveda Limited (ANL) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,341
of 5,047 stocks
▲ 91W▲ 901M
Peak #2,337 · 15 Nov 2026
A microcap name in Healthcare, Accretion Nutraveda Limited carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 73%.
Market Cap
249.78 Cr
P/E Ratio
49.28
P/B Ratio
7.04
ROE
14.29%
ROCE
16.98%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
Quarterly financials for this stock haven't been ingested yet — check back soon.
Shareholding pattern
Promoter
73.48%
Public
26.52%
PUBLIC BREAKDOWN
FII
1.08%
DII
6.10%
Individuals
15.85%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.